95 related articles for article (PubMed ID: 21678292)
1. Prolonged P wave dispersion in pre-diabetic patients.
Karabag T; Aydin M; Dogan SM; Cetiner MA; Sayin MR; Gudul NE; Kucuk E
Kardiol Pol; 2011; 69(6):566-71. PubMed ID: 21678292
[TBL] [Abstract][Full Text] [Related]
2. Increased P wave dispersion after the radiofrequency catheter ablation in overt pre-excitation patients: the role of atrial vulnerability.
Soylu M; Demir AD; Ozdemir O; Soylu O; Topaloğlu S; Korkmaz S; Saşmaz A
Int J Cardiol; 2004 Jun; 95(2-3):167-70. PubMed ID: 15193815
[TBL] [Abstract][Full Text] [Related]
3. The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow.
Güneş Y; Tuncer M; Güntekin U; Ceylan Y
Anadolu Kardiyol Derg; 2009 Aug; 9(4):290-5. PubMed ID: 19666430
[TBL] [Abstract][Full Text] [Related]
4. Predictors of atrial fibrillation after coronary artery bypass surgery.
Dogan SM; Buyukates M; Kandemir O; Aydin M; Gursurer M; Acikgoz S; Yavuzer R; Cam F; Dursun A
Coron Artery Dis; 2007 Aug; 18(5):327-31. PubMed ID: 17627180
[TBL] [Abstract][Full Text] [Related]
5. Relationship between P-wave dispersion and effective hemodialysis in chronic hemodialysis patients.
Ozmen N; Cebeci BS; Kardesoglu E; Atasoyu EM; Unver S; Celik T; Aparci M; Dincturk M
Med Princ Pract; 2007; 16(2):147-50. PubMed ID: 17303952
[TBL] [Abstract][Full Text] [Related]
6. Perindopril decreases P wave dispersion in patients with stage 1 hypertension.
Ozben B; Sumerkan M; Tanrikulu AM; Papila-Topal N; Fak AS; Toprak A
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):85-90. PubMed ID: 19502255
[TBL] [Abstract][Full Text] [Related]
7. The effect of rapid blood pressure control on P-wave dispersion in hypertensive urgency.
Karaca I; Durukan P; Dagli N; Yavuzkir M; Ikizceli I; Balin M
Adv Ther; 2008 Dec; 25(12):1303-14. PubMed ID: 19043679
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of P-wave duration and dispersion in patients with mitral stenosis.
Guntekin U; Gunes Y; Tuncer M; Gunes A; Sahin M; Simsek H
Pacing Clin Electrophysiol; 2008 Dec; 31(12):1620-4. PubMed ID: 19067816
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism.
Katircibasi MT; Deniz F; Pamukcu B; Binici S; Atar I
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):376-9. PubMed ID: 17701883
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease.
Berker D; Işik S; Canbay A; Aydin Y; Tütüncü Y; Delibaşi T; Güler S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):298-303. PubMed ID: 19666432
[TBL] [Abstract][Full Text] [Related]
11. P wave dispersion increases during hemodialysis sessions.
Ozben B; Toprak A; Koc M; Sumerkan M; Tanrikulu AM; Papila-Topal N; Kefeli US; Cincin AA; Baykan O; Fak AS
Nephron Clin Pract; 2009; 112(3):c171-6. PubMed ID: 19390218
[TBL] [Abstract][Full Text] [Related]
12. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
[TBL] [Abstract][Full Text] [Related]
13. P-wave duration and dispersion in patients with metabolic syndrome.
Yasar AS; Bilen E; Bilge M; Ipek G; Ipek E; Kirbas O
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1168-72. PubMed ID: 19719494
[TBL] [Abstract][Full Text] [Related]
14. P-wave durations in patients experiencing atrial fibrillation during exercise testing.
Ozdemir O; Soylu M; Demir AD; Topaloğlu S; Alyan O; Geyik B; Kutuk E
Angiology; 2007; 58(1):97-101. PubMed ID: 17351164
[TBL] [Abstract][Full Text] [Related]
15. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism.
Aras D; Maden O; Ozdemir O; Aras S; Topaloglu S; Yetkin E; Demir AD; Soylu MO; Erdogan MF; Kisacik HL; Korkmaz S
Int J Cardiol; 2005 Mar; 99(1):59-64. PubMed ID: 15721500
[TBL] [Abstract][Full Text] [Related]
16. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
Maia IG; Cruz Filho FE; Fagundes ML; Boghossian SH; Vanheusden L; Sa RM; Alves PA
J Am Coll Cardiol; 1995 Nov; 26(5):1310-4. PubMed ID: 7594048
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
[TBL] [Abstract][Full Text] [Related]
18. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
Gunes Y; Tuncer M; Guntekin U; Akdag S; Gumrukcuoglu HA
Pacing Clin Electrophysiol; 2009 Feb; 32(2):239-44. PubMed ID: 19170914
[TBL] [Abstract][Full Text] [Related]
19. [Detection of patients at risk for paroxysmal atrial fibrillation (PAF) by signal averaged P wave, standard ECG and echocardiography].
Michałkiewicz D; Dziuk M; Kamiński G; Olszewski R; Cholewa M; Cwetsch A; Markuszewski L
Pol Merkur Lekarski; 2006 Jan; 20(115):69-72. PubMed ID: 16617740
[TBL] [Abstract][Full Text] [Related]
20. Effect of obesity on P-wave dispersion and QT dispersion in women.
Seyfeli E; Duru M; Kuvandik G; Kaya H; Yalcin F
Int J Obes (Lond); 2006 Jun; 30(6):957-61. PubMed ID: 16432544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
